Healthcare Global Enterprises
Healthcare Global Enterprises Performance
Day Range
- Low 353
- High 359.95
52 Week Range
- Low 253.15
- High 380.35
- Open Price358.45
- Previous Close356.7
- Volume89615
Start SIP in Healthcare Global Enterprises
Start SIPHealthcare Global Enterprises Investment Rating
-
Master Rating:
-
Healthcare Global Ents. has an operating revenue of Rs. 1,747.07 Cr. on a trailing 12-month basis. An annual revenue growth of 21% is outstanding, Pre-tax margin of 3% needs improvement, ROE of 3% is fair but needs improvement. The company has a reasonable debt to equity of 42%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 17% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 53 which is a POOR score indicating inconsistency in earnings, a RS Rating of 58 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 99 indicates it belongs to a poor industry group of Medical-Hospitals and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
Indicator | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
---|---|---|---|---|---|---|
Oper Rev Qtr Cr | 272 | 259 | 253 | 253 | 243 | 220 |
Operating Expenses Qtr Cr | 225 | 219 | 203 | 206 | 197 | 180 |
Operating Profit Qtr Cr | 48 | 40 | 50 | 47 | 46 | 40 |
Depreciation Qtr Cr | 22 | 23 | 22 | 22 | 22 | 22 |
Interest Qtr Cr | 10 | 10 | 11 | 12 | 10 | 9 |
Tax Qtr Cr | 4 | 4 | 5 | 3 | 6 | 2 |
Net Profit Qtr Cr | 14 | 4 | 14 | 11 | 11 | -18 |
Healthcare Global Enterprises Technicals
EMA & SMA

- Bullish Moving Average
- ___
- 15
- Bearish Moving Average
- ___
- 1
- 20 Day
- ₹353.95
- 50 Day
- ₹345.24
- 100 Day
- ₹330.6
- 200 Day
- ₹312.88
- 20 Day
- ₹359.89
- 50 Day
- ₹344.61
- 100 Day
- ₹328.96
- 200 Day
- ₹303.41
Healthcare Global Enterprises Resistance and Support
Resistance | |
---|---|
First Resistance | ₹360.7 |
Second Resistance | ₹363.8 |
Third Resistance | ₹367.65 |
RSI | 54.35 |
MFI | 28.93 |
MACD Single Line | 3.2 |
MACD | 1.52 |
Support | |
---|---|
First Resistance | ₹353.75 |
Second Resistance | ₹349.9 |
Third Resistance | ₹346.8 |
Healthcare Global Enterprises Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 93,821 | 4,312,013 | 45.96 |
Week | 272,542 | 12,013,643 | 44.08 |
1 Month | 228,741 | 12,091,274 | 52.86 |
6 Month | 163,390 | 9,988,007 | 61.13 |
Healthcare Global Enterprises Result Highlights
Healthcare Global Enterprises Synopsis
NSE-Medical-Hospitals
Healthcare Global En is involved in the business activities of Hospital activities. Company’s Total Operating Revenue is Rs. 1005.57 Cr. and Equity Capital is Rs. 139.12 Cr. for the Year ended 31/03/2023. Healthcare Global Enterprises Ltd. is a Public Limited Listed company incorporated on 12/03/1998 and has its registered office in the State of Karnataka, India. Company’s Corporate Identification Number(CIN) is L15200KA1998PLC023489 and registration number is 023489.Market Cap | 4,980 |
Sales | 1,037 |
Shares in Float | 4.04 |
No of funds | 61 |
Yield |
Book Value | 4.34 |
U/D Vol ratio | 1.2 |
LTDebt / Equity | 10 |
Alpha | 0.07 |
Beta | 0.32 |
Healthcare Global Enterprises
Owner Name | Jun-23 | Mar-23 | Dec-22 | Sep-22 |
---|---|---|---|---|
Promoters | 71.35% | 71.37% | 71.38% | 71.39% |
Mutual Funds | 4.56% | 3.87% | 3.01% | 2.81% |
Insurance Companies | 0.37% | 0.4% | 0.4% | 0.62% |
Foreign Portfolio Investors | 6.47% | 6.37% | 7.18% | 7.27% |
Individual Investors | 10.43% | 11.44% | 11.6% | 11.21% |
Others | 6.82% | 6.55% | 6.43% | 6.7% |
Healthcare Global Enterprises Management
Name | Designation |
---|---|
Dr. B S Ajai Kumar | Executive Chairman |
Ms. Anjali Ajaikumar Rossi | Executive Director |
Mr. Shanker Annaswamy | Independent Director |
Mr. Abhay Prabhakar Havaldar | Non Exe. & Ind. Director |
Ms. Geeta Mathur | Non Exe. & Ind. Director |
Mr. Rajagopalan Raghavan | Non Exe. & Ind. Director |
Mr. Siddharth Patel | Non Exe.Non Ind.Director |
Mr. Amit Soni | Non Exe.Non Ind.Director |
Mr. Meghraj Arvindrao Gore | WholeTime Director & CEO |
Mr. Jeyandran Venugopal | Non Exe. & Ind. Director |
Mr. Pradip Kanakia | Non Exe. & Ind. Director |
Healthcare Global Enterprises Forecast
Price Estimates
Healthcare Global Enterprises Corporate Action
Date | Purpose | Remarks |
---|---|---|
2023-08-10 | Quarterly Results & ESOP | |
2023-05-25 | Audited Results | |
2023-02-09 | Quarterly Results | |
2022-11-10 | Quarterly Results | |
2022-08-10 | Quarterly Results |
- Company Name
- CMP
- Chg(%)
- Hindalco Inds.
- 493
- 5.5
- NTPC
- 246
- 3.6
- Hero Motocorp
- 3057
- 2.9
- Dr Reddys Labs
- 5587
- 2.9
- Divis Lab.
- 3765
- 2.7
- Company Name
- CMP
- Chg(%)
- Adani Enterp.
- 2414
- -2.5
- LTIMindtree
- 5210
- -1.0
- HCL Technologies
- 1235
- -0.6
- Tech Mahindra
- 1223
- -0.5
- Power Grid Corpn
- 200
- -0.5
Healthcare Global Enterprises FAQs
What is Share Price of Healthcare Global Enterprises ?
Healthcare Global Enterprises share price is ₹357 As on 30 September, 2023 | 15:52
What is the Market Cap of Healthcare Global Enterprises ?
The Market Cap of Healthcare Global Enterprises is ₹4979.8 Cr As on 30 September, 2023 | 15:52
What is the P/E ratio of Healthcare Global Enterprises ?
The P/E ratio of Healthcare Global Enterprises is 161.2 As on 30 September, 2023 | 15:52
What is the PB ratio of Healthcare Global Enterprises ?
The PB ratio of Healthcare Global Enterprises is 5.7 As on 30 September, 2023 | 15:52